• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国儿童终末期肾病患者的治疗方式模式与移植情况:一项纵向研究

Treatment modality patterns and transplantation among the United States pediatric end-stage renal disease population: a longitudinal study.

作者信息

Held P J, Turenne M N, Liska D W, Zobel D L, Webb R L, Alexander S R, Jones C

机构信息

United States Renal Data System, Bethesda, Maryland.

出版信息

Clin Transpl. 1991:71-85.

PMID:1820148
Abstract

Between 1985 and 1988, there were 3,393 children (Medicare insured) under age 20 who began treatment for chronic ESRD. Patterns of modality use, modality switch, mortality rates, and various aspects of transplantation were analyzed for different age and incident groups of this pediatric cohort. The pediatric cohort as a whole exhibited a distinct pattern of modality use when compared to adults in general, a point evidenced most clearly by their substantially higher rates of transplantation. Furthermore, notable differences were found within the pediatric cohort when the younger than 5, 5-9, 10-14, and 15- to 19-year-old age groups were analyzed separately. Younger pediatric patients, particularly those younger than 5 years, received peritoneal dialysis as initial ESRD therapy more frequently than their older pediatric counterparts. This result would be expected given vascular access problems often associated with very young patients. In addition, those patients younger than 5 years who began RRT with some form of hemodialysis had the highest likelihood of switching to CAPD/CCPD within the first year of therapy. Conversely, older pediatric patients were most likely to begin RRT therapy with some form of hemodialysis. By day 91, slightly over half of the 15- to 19-year-old age group was utilizing center hemodialysis; the CAPD/CCPD, other peritoneal, and functioning transplant modalities each contained about 10% of the patients with the remainder falling into the death and unknown dialysis categories. The overall pattern of switching to transplantation during the first year of RRT was similar for pediatric patients initiating RRT with center hemodialysis versus peritoneal dialysis (CAPD/CCPD), but differed by age group within each dialysis type. Pediatric patients on peritoneal dialysis were somewhat more likely to receive a transplant during the first year of ESRD compared to hemodialysis, although the difference was small. Mortality rates during the first year for patients who began treatment with center hemodialysis versus CAPD/CCPD were similar. The well-documented dominance of transplantation as a method of RRT for pediatric patients was further verified by this study. Results show that transplantation was implemented rapidly during the initial months of ESRD. Nearly 50% of surviving pediatric patients had a functioning transplant at 1 year following onset and 64% at 3 years. These percentages were exceeded for the 5- to 9-year-old age group, of which 74% had a functioning graft 3 years following onset.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

1985年至1988年间,有3393名20岁以下的儿童(参加了医疗保险)开始接受慢性终末期肾病的治疗。对这个儿科队列的不同年龄和发病组的治疗方式使用模式、治疗方式转换、死亡率以及移植的各个方面进行了分析。与一般成年人相比,整个儿科队列呈现出独特的治疗方式使用模式,这一点最明显的证据是他们的移植率显著更高。此外,当分别分析5岁以下、5至9岁、10至14岁以及15至19岁年龄组时,在儿科队列中发现了显著差异。年龄较小的儿科患者,尤其是5岁以下的患者,作为初始终末期肾病治疗接受腹膜透析的频率高于年龄较大的儿科患者。考虑到与非常年幼患者经常相关的血管通路问题,这个结果是可以预期的。此外,那些以某种形式的血液透析开始肾脏替代治疗(RRT)的5岁以下患者在治疗的第一年内转换为持续性非卧床腹膜透析(CAPD)/持续性循环腹膜透析(CCPD)的可能性最高。相反,年龄较大的儿科患者最有可能以某种形式的血液透析开始RRT治疗。到第91天时,15至19岁年龄组略超过一半的患者在使用中心血液透析;CAPD/CCPD、其他腹膜透析以及有功能的移植治疗方式各包含约10%的患者,其余患者归入死亡和未知透析类别。对于以中心血液透析与腹膜透析(CAPD/CCPD)开始RRT的儿科患者,在RRT第一年转换为移植的总体模式相似,但在每种透析类型内按年龄组有所不同。与血液透析相比,接受腹膜透析的儿科患者在终末期肾病的第一年内接受移植的可能性略高,尽管差异很小。以中心血液透析与CAPD/CCPD开始治疗的患者在第一年的死亡率相似。这项研究进一步证实了移植作为儿科患者RRT方法的显著优势。结果表明,在终末期肾病的最初几个月内移植迅速实施。近50%的存活儿科患者在发病后1年有有功能的移植,3年时为64%。5至9岁年龄组超过了这些百分比,其中74%在发病后3年有有功能的移植物。(摘要截选至400字)

相似文献

1
Treatment modality patterns and transplantation among the United States pediatric end-stage renal disease population: a longitudinal study.美国儿童终末期肾病患者的治疗方式模式与移植情况:一项纵向研究
Clin Transpl. 1991:71-85.
2
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
3
Survival on renal replacement therapy: data from the EDTA Registry.肾脏替代治疗的生存率:来自欧洲透析和移植协会(EDTA)登记处的数据。
Nephrol Dial Transplant. 1988;3(2):109-22.
4
Mortality risks of peritoneal dialysis and hemodialysis.腹膜透析和血液透析的死亡风险。
Am J Kidney Dis. 1999 Dec;34(6):1065-74. doi: 10.1016/S0272-6386(99)70012-0.
5
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
6
The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients.1998年日本国家登记处关于小儿终末期肾病患者的数据报告。
Pediatr Nephrol. 2002 Jun;17(6):456-61. doi: 10.1007/s00467-002-0848-8.
7
ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.千禧年末澳大利亚和新西兰的终末期肾病:来自澳新透析与移植登记处的报告
Am J Kidney Dis. 2002 Dec;40(6):1122-31. doi: 10.1053/ajkd.2002.36943.
8
Pediatric renal transplantation--the NAPRTCS experience.小儿肾移植——北美小儿肾移植协作研究组的经验
Clin Transpl. 1997:87-100.
9
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience].[意大利透析与移植登记处:1996 - 2001年经验]
G Ital Nefrol. 2004 Nov-Dec;21(6):561-7.
10
Characteristics and survival of young adults who started renal replacement therapy during childhood.童年期开始肾脏替代治疗的年轻成年人的特征与生存情况。
Nephrol Dial Transplant. 2009 Mar;24(3):926-33. doi: 10.1093/ndt/gfn542. Epub 2008 Oct 7.

引用本文的文献

1
Impact of the Type of Dialysis on Time to Transplantation: Is It Just a Matter of Immunity?透析类型对移植时间的影响:这仅仅是免疫的问题吗?
J Clin Med. 2022 Feb 17;11(4):1054. doi: 10.3390/jcm11041054.